SCHEMBL30360666

SCHEMBL30360666

Cc1ccc(Br)c(CCO)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
AMY1A P0DUB6 1/20 0.37
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 1/20 0.34
TRPA1 O75762 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
HSP90AA1 P07900 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP1A2 P05177 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16011491 1.00 FFAR4 (0.40) FFAR4TAAR1AMY1AALDH1A1SMN1; SMN2
SCHEMBL17429675 0.83 SMN1; SMN2 (0.37) TAAR1ALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL2790749 0.83 AMY1A (0.39) FFAR4TAAR1AMY1AALDH1A1SMN1; SMN2
SCHEMBL27570578 0.81 TAAR1 (0.41) FFAR4TAAR1AMY1AALDH1A1SMN1; SMN2
SCHEMBL12311975 0.79 TAAR1 (0.64) FFAR4TAAR1CYP1A2CYP2A6
SCHEMBL698983 0.78 TAAR1 (0.63) TAAR1AMY1AALDH1A1TRPA1NPC1
SCHEMBL29710612 0.78 CHEK1 (0.40) ALDH1A1HPGDTSHRHSP90AA1L3MBTL1
SCHEMBL38658478 0.78 TAAR1 (0.63) TAAR1AMY1AALDH1A1TRPA1NPC1
SCHEMBL1569443 0.78 CHEK1 (0.40) ALDH1A1HPGDTSHRHSP90AA1L3MBTL1
SCHEMBL24376119 0.78 TYR (0.40) FFAR4TAAR1ALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111925360-B 1-heterocyclylisochromanyl compounds and analogs for the treatment of CNS disorders 赛诺维信制药公司 2024-03-22 CN disclosed
CN-116514761-A Compounds, compositions and uses thereof 赛诺维信制药公司 2023-08-01 CN disclosed
CN-116283877-A Compounds, compositions and uses thereof 赛诺维信制药公司 2023-06-23 CN disclosed
CN-110088107-B Compounds, compositions and uses thereof 赛诺维信制药公司 2023-04-14 CN disclosed